Catalyst Pharmaceuticals
CPRX
#3987
Rank
โ‚น298.47 B
Marketcap
โ‚น2,428
Share price
1.43%
Change (1 day)
29.50%
Change (1 year)

Market capitalization of Catalyst Pharmaceuticals (CPRX)

Market cap: โ‚น298.47 Billion

As of April 2026 Catalyst Pharmaceuticals has a market cap of โ‚น298.47 Billion. This makes Catalyst Pharmaceuticals the world's 3987th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalyst Pharmaceuticals from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น298.47 B11.09%
2025โ‚น268.67 B22.3%
2024โ‚น219.68 B47.25%
2023โ‚น149.19 B-6.86%
2022โ‚น160.18 B208.65%
2021โ‚น51.89 B104.72%
2020โ‚น25.35 B-8.32%
2019โ‚น27.65 B100.47%
2018โ‚น13.79 B-46.09%
2017โ‚น25.58 B332.52%
2016โ‚น5.91 B-56.15%
2015โ‚น13.48 B3.68%
2014โ‚น13.01 B99.5%
2013โ‚น6.52 B561.04%
2012โ‚น0.98 B-41.47%
2011โ‚น1.68 B95.92%
2010โ‚น0.86 B63.17%
2009โ‚น0.52 B-56.65%
2008โ‚น1.21 B-28.28%
2007โ‚น1.69 B-36.65%
2006โ‚น2.67 B

End of Day market cap according to different sources

On Apr 18th, 2026 the market cap of Catalyst Pharmaceuticals was reported to be:

โ‚น296.56 Billion
by Nasdaq info icon info icon
โ‚น298.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚น52.187 T 17,384.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น14.497 T 4,757.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น15.556 T 5,111.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
โ‚น209.22 B-29.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚น75.92 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น971.76 B 225.58%๐Ÿ‡บ๐Ÿ‡ธ USA